Personalizing Hemophilia Care Through Shared Decision-Making – EAHAD
European Association for Haemophilia and Allied Disorders (EAHAD) shared a post on LinkedIn about a recent article by Quentin Van Thillo et al, published in Haemophilia, adding:
“With an increasing number of innovative treatment options available, choosing the most appropriate therapy requires careful consideration of individual patient needs and preferences.
Check out the recently published article on Haemophilia Journal exploring 15 key treatment differentiators to support clinicians in shared decision-making discussions, complementing the existing World Federation of Hemophilia.”
Title: Shared Decision-Making in Haemophilia Involves More Treatment Differentiators in 2026
Authors: Quentin Van Thillo, Guy Young, Cedric Hermans
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 6, 2026, 08:22How Bleeding Disorders Affect Social Life and Well-Being? – EHC
-
Nov 6, 2026, 08:13Jared Rice: Why Neonatal Coagulation Cannot Be Interpreted Like Adult Coagulation
-
Nov 6, 2026, 08:07Matthew Smeds: Endovascular Salvage of Acute IVC Thrombosis After Liver Transplantation
-
Nov 6, 2026, 07:54Jennifer Cogley: Bayer Employees Unite to Support Bleeding Disorders Awareness
-
Nov 6, 2026, 07:30Mapillar Dahn: Advancing Stem Cell-Derived Red Blood Cells
-
Nov 6, 2026, 07:26Denis Oduor: Strengthening Blood Safety – Mbagathi County Hospital Setting the Pace
-
Nov 6, 2026, 07:21Minh-Ha Tran: Enabling Heparin Anticoagulation Despite HIT
-
Nov 6, 2026, 04:37Jacopo Imberti: When to Stop Anticoagulation After Successful PVI
-
Nov 6, 2026, 04:28George Vlasuk: A New LMWH Without the Risk of HIT?